Xenetic Biosciences, Inc. (XBIO) SEC Filings & Financial Intelligence
Xenetic Biosciences, Inc. (XBIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XBIO
CIK: 1534525
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerKevin Burkhardt
Audit LocationHartford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-23 | 2026-09-23 | CURRENT REPORT | 0001683168-26-007340 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-18 | — | SCHEDULE 13G Filing | 0002103370-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-14 | FORM 8-K | 0001683168-26-007181 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | FORM 8-K | 0001683168-26-006077 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | FORM 10-Q FOR JUN 2026 | 0001683168-26-006061 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-29 | — | SCHEDULE 13G Filing | 0002103370-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001037389-26-000042 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | FORM 8-K | 0001683168-26-003766 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | QUARTERLY REPORT FOR MARCH 2026 | 0001683168-26-003727 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-24 | 2025-12-31 | FORM 10-K FOR DEC 2025 AMENDMENT 1 | 0001683168-26-003207 | View SEC Doc Filr Page |
| 8-K | 2026-04-24 | 2026-04-21 | CURRENT REPORT | 0001683168-26-003203 | View SEC Doc Filr Page |
| 4 | 2026-04-23 | 2026-04-21 | 4 Filing | 0001683168-26-003163 | View SEC Doc Filr Page |
| 8-K | 2026-03-13 | 2026-03-13 | CURRENT REPORT | 0001683168-26-001744 | View SEC Doc Filr Page |
| 10-K | 2026-03-12 | 2025-12-31 | FORM 10-K FOR DEC 2025 | 0001683168-26-001737 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-12 | — | SCHEDULE 13G Filing | 0001037389-26-000022 | View SEC Doc Filr Page |
| 8-K | 2026-01-09 | 2026-01-08 | FORM 8-K | 0001683168-26-000196 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2025-12-31 | 4 Filing | 0001683168-26-000104 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2025-12-31 | 4 Filing | 0001683168-26-000103 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2025-12-31 | 4 Filing | 0001683168-26-000102 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2025-12-31 | 4 Filing | 0001683168-26-000101 | View SEC Doc Filr Page |
| DEFA14A | 2025-12-11 | — | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | 0001683168-25-009077 | View SEC Doc Filr Page |
| 8-K | 2025-12-11 | 2025-12-11 | CURRENT REPORT | 0001683168-25-009076 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-13 | CURRENT REPORT | 0001683168-25-008288 | View SEC Doc Filr Page |
| 10-Q | 2025-11-12 | 2025-09-30 | FORM 10-Q FOR SEP 2025 | 0001683168-25-008259 | View SEC Doc Filr Page |
| ARS | 2025-10-31 | 2024-12-31 | ANNUAL REPORT TO SECURITY HOLDERS | 0001683168-25-007876 | View SEC Doc Filr Page |